Is Day 3 vs Day 5-7 Assisted Hatching Helpful in IVF with PGT-A
Official title: The IMPACT Trial: Investigating Micro-Manipulation Procedures for Assisted Hatching Timing
Run by Reproductive Medicine Associates of New Jersey · NCT06377917 · Data updated 2026-11-12
This trial tests whether performing assisted hatching at Day 3 or at the blastocyst stage (Day 5-7) helps patients undergoing IVF with PGT-A to improve outcomes, using a within-patient split design.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 42 Years |
| Sex | Women only |
| Enrollment | 75 (estimated) |
| Sponsor | Reproductive Medicine Associates of New Jersey Academic / other |
| Locations | 1 site (Marlton, New Jersey) |
| Status | Recruiting |
| Started | May 31, 2026 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2028 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT06377917 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Fertility patients undergoing an IVF cycle with plan for a single euploid embryo transfer, under age 42, with adequate ovarian reserve and BMI under 38, and two PN zygotes available for randomization.
✕Probably not a fit
Patients not responding to this approach or those not meeting eligibility criteria may see no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study uses a split-cohort design where each participant's fertilized embryos are randomized to either Day 3 cleavage-stage assisted hatching or sequential Day 5-7 blastocyst-stage hatching with TE biopsy. Each patient serves as her own control to reduce confounding. Laser-assisted hatching is the intervention under evaluation. Eligible participants are those undergoing an IVF cycle with plans for a single euploid embryo transfer after PGT-A, with specific age and ovarian reserve criteria, and BMI under 38. The study aims to determine the clinical significance of the different timing of assisted hatching in the context of euploid embryo transfer.
Why it matters
Potential benefit: If successful, this approach could improve embryo viability and improve chances of a successful euploid embryo transfer.
How similar studies have gone: Previous work has explored assisted hatching timing, but this specific split-cohort, within-patient randomization is relatively novel in the PGT-A context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for participants: 1. Patients undergoing an IVF cycle with plan for subsequent FET of a single euploid embryo 2. \<4 2PNs prior to randomization 3. Female partners age \<42 years old at start of VOR cycle 4. Normal ovarian reserve: 1. AMH ≥ 1.2 ng/mL 2. AFC ≥ 8 3. FSH ≤ 12IU/L 5. BMI \<38 6. Patients who desire to transfer the best quality embryo for their embryo transfer. Exclusion Criteria for participants: 1. All patients who do not voluntarily give their written consent for participation 2. Patients with a prior failed IVF cycle - defined as no blastocysts 3. Patients with a history of more than one failed euploid embryo transfer 4. Donor oocyte cycles 5. Gestational Carriers 6. Male partner with \<100,000 total motile spermatozoa per ejaculate (donor sperm is acceptable) 7. Use of surgical procedures to obtain sperm 8. Communicating hydrosalpinges without a plan for surgical correct prior to frozen embryo transfer 9. Endometrial Insufficiency, as defined by a prior cycle with maximal endometrial thickness \<6mm,), or persistent endometrial fluid 10. Single gene disorders, chromosomal translocations, or any other disorders requiring a more detailed embryo genetic analysis than standard PGT-A
Where it's running
-
Reproductive Medicine Associates of New Jersey
Marlton, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Jason Fransiak, MD — Reproductive Medicine Associates of New Jersey
- Study coordinator: Christine V Whitehead, MS, BSN, RN
- Email: clinicalresearchteam@ivirma.com
- Phone: 19736562841
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted embryo selection on day 5 in IVF for infertility
This trial tests whether an AI-based embryo selection tool can help pick the best embryo for transfer on day 5 in IVF/ICSI to improve pregnancy chances for people with infertility.
-
Preserving sperm quality with aging through cryopreservation
This study tests whether freezing and thawing sperm can help keep younger-like DNA and molecular traits in men as they age.
-
Unstimulated Egg Retrieval with CAPA-IVM and Euploid Embryo Transfer
This study tests whether eggs can be collected without ovarian stimulation, matured in the lab, and used to create a single euploid embryo for transfer in infertility patients.
-
Ultra-Long GnRH-a Pretreatment Before Frozen Embryo Transfer for Deep Infiltrating Endometriosis
In people under 40 with deep infiltrating endometriosis and infertility, the study tests whether two injections of a GnRH agonist before hormone support improve pregnancy outcomes in their first frozen-thawed embryo transfer.
-
Endometrial Waves and Pregnancy in FET Cycles with Hormone Therapy
This study tests whether patterns of uterine contractions during hormone-prepared frozen embryo transfer affect pregnancy outcomes.
-
Environmental and lifestyle factors linked to ART success in infertility patients
This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.